Acute myeloid leukemia: open trials in Israel

9 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Carmel Medical Center, Haifa · Rambam Med.Center - Hematology Institute, Haifa · Rambam Medical Center, Haifa · Hadassah University Hospita Ein Kerem, Jerusalem · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-04
NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Shamir Medical Center Assaf Harofeh, Beer Yaakov · Rambam Medical Center, Haifa · Carmel Medical Center, Haifa · Shaare Zedek Medical Center, Jerusalem · Hadassah University Hospita Ein Kerem, Jerusalem · Rabin Medical Center, Petah Tikva · Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-03
NCT05429632
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Trial Treatment · Phase 3 · Priothera SAS
Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · The Tel Aviv Sourasky Medical Center, Tel Aviv · The Chaim Sheba Medical Center, Tel-Hashomer
Registry updated 2026-10-30
NCT07581002
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 2/3 · AbbVie
Rambam Health Care Campus- Haifa /ID# 278719, Haifa · Hadassah Medical Center-Hebrew University /ID# 278866, Jerusalem · Shaare Zedek Medical Center /ID# 278712, Jerusalem · Rabin Medical Center /ID# 278714, Petah Tikva · Tel Aviv Sourasky Medical Center /ID# 278717, Tel Aviv
Registry updated 2026-10-22
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Haifa · Jerusalem · Petah Tikva · Tel Aviv · Tel HaShomer
Registry updated 2026-10-21
NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE
Research · JaxBio Ltd
Tel Aviv Sourasky Medical Center - TASMC, Tel Aviv
Registry updated 2026-10-15
NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals
Rambam Health Care Campus (RHCC), Haifa · Shaare Zedek Medical Center, Jerusalem · Hadassah Medical Center - Ein Kerem, Jerusalem · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan
Registry updated 2026-10-09
NCT05477589
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Trial Treatment · Phase 3 · Vastra Gotaland Region
Schneider Children's Medical Center of Israel, Petah Tikva
Registry updated 2024-12-19
NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Trial Treatment · Phase 2 · Associazione Italiana Ematologia Oncologia Pediatrica
Rappaport Children'S Hospital, Rambam Health Care Campus, Haifa
Registry updated 2024-04-15

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error